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Abstract A cohort study with prospective data collection was conducted to determine which
risk factors and outcome variables are statistically significant clinical predictors of mortality
from infective endocarditis. A study was performed from an eleven-year, hospitalization
cohort (NZ 11,230) in which the data were collected prospectively. The study examined 21
potential risk factors and 14 outcome variables. The risk factors were categorized into these
various groups: patient factors, cardiac factors, co-morbidities, operative factors, infectious
factors, and complications. The outcome variables were categorized into operative factors, in-
fectious factors, and complications. Inclusion criteria included patients with endocarditis
(NZ 87). Longer operative time, operative complications, and postoperative complications.
Overall mortality was 11.5 percent (NZ 10). Endocarditis patients who died were significantly
older (pZ 0.023) and had a longer pump time (pZ 0.017) than those who survived. Endocar-
ditis patients who died were more likely to experience an unstable hemodynamic status
(pZ 0.012). There was a significant difference between survival and non-survival of patients
with endocarditis on nine outcome variables. They were more likely to require a re-operation
for bleeding (pZ 0.034). Renal complications (pZ 0.016), neurological complications
(p Z 0.004), pulmonary complications (p Z 0.001), intra-operative complications
(pZ 0.035), and IAPB (p < 0.001) were all more likely to occur in endocarditis patients who
died. There are risk factors that serve as predictors of mortality from infectious endocarditis.
These include age greater than 65 years, longer pump time, and unstable hemodynamic status.
Abbreviations: BSA, body surface area; ICU, intensive care unit; IABP, intra-aortic balloon pump; NYHA, New York Heart Association.
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Infective endocarditis is a serious, often fatal illness. There
are 10,000 to 15,000 newly diagnosed cases each year.1 It
continues to be a challenging disease to manage despite
the major advances in diagnostic technology, improve-
ments in antimicrobial selection, and advances in surgical
techniques. Endocarditis remains a disease with a high
mortality rate, with in-hospital mortality rates in the con-
temporary era of nearly 20%.2 Netzer et al. reported that
factors predictive of long term mortality included age
greater than 55 years, congestive heart failure, and the ini-
tial presence of few symptoms of endocarditis.3 They also
found that early valve replacement has the potential to
improve long-term survival. Chu and colleagues focused on
early, independent determinants of in-hospital death from
infectious endocarditis. Wallace et al. identified clinical
findings within 48 h of admission that influenced both short
and longer-term outcomes.
Clinicians caring for patients with endocarditis need to
be able to accurately identify patients who are at highest
risk for death early in the course of their illness. It is also
important to determine the prognostic factors that improve
long-term survival outcome. The present study will focus on
potential risk factors of endocarditis that may result in
mortality. This study will also examine outcomes other than
mortality that result from endocarditis.
Methods
A cohort study from an eleven-year, prospective hospital-
ization cohort (NZ 11,230) was conducted. Nurses,
physicians, and perfusionists collected data on 225 vari-
ables during admission. Data were grouped into demo-
graphic, medical history, postoperative, perfusion, and
procedure sections. Using a series of crosschecking ques-
tions, two individuals audited all data forms for complete-
ness and consistency. To further ensure accuracy and
consistency, a physician audited a random 10% of patient
forms. Data then were entered into an interactive multi-
institutional database (Patient Analysis and Tracking
System, Axis Clinical Systems, Portland, OR).
Included in the study were patients age 18 and above
diagnosed with infective endocarditis between October
1993 and February 2004 (NZ 87). The study examined 21
potential risk factors. The continuous risk factors included
age, creatinine level, pump time, cross-clamp time, body
surface area (BSA), and annulus size. Categorical risk fac-
tors included gender, other systemic diseases, significant
associated disorders, diabetes, previous cardiac surgery,
operative category, cor sinus CP site, urgent surgical proce-
dure, hemodynamic status, New York Heart Association
functional class (NYHA), cardiac pathology, drugs wean,procedure site, surgical procedure, infection, vegetation
valve, abscess valve, and type of prothesis.
The 14 outcome variables other than mortality were
total hours on ventilator, intensive care unit (ICU) length of
stay, total length of hospital stay, reoperation for bleeding,
arrhythmias, positive blood culture, positive cultures
(blood, urine, venous line, arterial line), renal complica-
tion, wound complications, neurological complications,
pulmonary complications, low output, intra-aortic balloon
pump (IAPB), pulmonary hypertension, and intra-operative
complications.
To generate the unadjusted risks of each potential risk
factor, Chi-square, or Fishers exact test when appropriate,
and t-tests comparing survival and non-survival patients
with each of the 21 risk factors were performed. Multivariate
regression was used to generate the adjusted risk for the sig-
nificant risk factors. Chi-square, or Fishers exact test, and t-
tests were also conducted comparing survival and non-sur-
vival patients with each of the 14 additional outcomes. We
used SPSS (SPSS Corporation, Chicago, Illinois) statistical
software to perform the analyses.
Results
In-house mortality occurred in 11.5 percent (NZ 10)
cases. Univariate analysis on potential risk factors re-
vealed three significant risk factors (Table 1). Endocarditis
patients who died were significantly older (pZ 0.023) and
had a longer pump time (pZ 0.017) and were more likely
to experience an unstable hemodynamic status (pZ
0.012). Mortality was significantly greater in patients older
than 65 years of age, who had pump times longer than
216 min, and in those who were hemodynamically unstable
defined as patients who were treated with intravenous
pressors or inotropes during their index admission. There
was no significant difference in mortality for endocarditis
patients in the remaining 18 risk factors. Multivariate re-
gression was used to generate the adjusted risk for the
three significant risk factors. Regression analysis revealed
a significant difference between endocarditis patients
with hemodynamic status (RRZ 10.5, 95% CIZ 1.9e56.9,
pZ 0.006) and pump time (RRZ 0.99, 95% CIZ 0.98e
0.99, pZ 0.025). Age was not significantly different
between the two groups in the multivariate analysis (RRZ
0.95, 95% CIZ 0.89e1.0, pZ 0.075).
There was a significant difference between survival
and non-survival of patients with endocarditis on six
outcome variables (Table 2). Endocarditis patients who
died were more likely to require a re-operation for blee-
ding (pZ 0.034). Renal complications (pZ 0.016), neuro-
logical complications (pZ 0.004), pulmonary complications
(0.001), intra-operative complications (pZ 0.035), and
IAPB (p < 0.001) were all more likely to occur in endocarditis
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Control Deceased Alive p-value
Hemodynamic status (unstable) 5 (33%) 5 (10%) 0.012
Sex (male) 7 (13%) 45 (86%) 0.734
Other systematic disorders 1 (7%) 13 (93%) 1.00
Significant associated disorders 2 (6%) 33 (94%) 0.300
Diabetes 4 (22%) 14 (78%) 0.205
Previous cardiac surgery 3 (12%) 21 (88%) 1.00
Operative category (valve) 6 (9%) 58 (91%) 0.409
CP site-coronary sinus 8 (12%) 58 (88%) 1.00
Urgent surgery procedure 4 (11%) 31 (89%) 0.987
Hemodynamic status (stable) 5 (7%) 67 (93%) 0.012
Code NYHA (I or II) 1 (3%) 31 (97%) 0.083
Procedure (valve replacement) 5 (11%) 39 (89%) 0.776
Etiology-infection 7 (11%) 57 (89%) 1.00
Vegetation valve 4 (9%) 42 (91%) 0.657
Abscess valve 4 (18%) 18 (82%) 0.171
Type of prosthesis (mechanical) 2 (9%) 20 (91%) 0.665
Mean  SD Mean  SD p-value
Age (years) 65.1  15.5 53.9  14.2 0.023
Pump time (min) 155.9  74.3 216.9  71.8 0.017
Creatinine level 1.944  1.1271 1.575  14.210 0.445
Cross clamp time 153.90  68.380 113.51  63.303 0.064
Body surface area (BSA) 1.9170  0.28848 1.9469  0.24649 0.724
Annulus size 23.50  2.950 25.67  3.238 0.121patients who died. There was no significant difference in
mortality for the remaining eight outcomes.
Discussion
Several retrospective studies have defined clinical and
laboratory findings that may have prognostic importance.4From 1996 to 2001, Chu et al. conducted a study of 351 pa-
tients diagnosed with IE. Their results demonstrated several
independent variables associated with greater risk for
in-house mortality.2 These risk factors were: male gender,
diabetes mellitus, S. aureus etiology, APACHE II score at
admission, and embolic event. Wallace et al. found among
clinical, microbiological, and echocardiographic features,
only white blood cell count and serum albumin wereTable 2 Univariate analysis of significant hospitalization outcome variables
Outcome Deceased Alive p-value
Re-operation for bleeding 2 (20%) 1 (1.3%) 0.034
Arrhythmia (pacer required) 5 (21%) 19 (79%) 0.092
Positive cultures
(blood, urine, arterial, venous)
3 (27%) 9 (73%) 0.086
Sternal wound complications 0 (0%) 1 (100%) 1.00
Low output 8 (14%) 49 (86%) 0.484
Pulmonary hypertension 2 (10%) 17 (90%) 1.00
Renal complications 5 (62.5%) 15 (20%) 0.016
Neurologic complications 5 (63%) 10 (13%) 0.004
Pulmonary complications 7 (88%) 19 (25%) 0.001
IABP 4 (40%) 1 (1.3%) <0.001
Intra-operative complications 2 (20%) 1 (1.3%) 0.035
Mean  SD Mean  SD
Operating hours on ventilator 7.29  1.6 5.36  1.4 0.001
ICU length of stay 248.80  307.092 101.14  235.295 0.075
Days total 12.56  8.960 15.26  14.372 0.584
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tion to our study, Wallace et al. concluded that age was not
a significant predictor of mortality and that abnormal serum
creatinine levels was a predictor of poorer outcome.
Eighteen patients in our cohort had diabetes mellitus at
the time of admission (21%). However, it was not found to
be clinically significant in our study (OR 3.00, 95% CI .746 to
12.061). Recent reports have demonstrated higher mortal-
ity in diabetics and it likely related to the adverse effects of
hyperglycemia on immune function.2 A recent randomized,
controlled trial by Van den Berghe et al. in 2001 showed
that intensive control of hyperglycemia with insulin ther-
apy, regardless of diabetic status, reduced the mortality
rate in critically ill patients.5 Our data is reflective of the
use of insulin therapy for tight control of hyperglycemia
amongst our patients with IE.
To our knowledge, there are no randomized, controlled
studies of cardiac surgery for IE. Currently, cardiac surgery
is recommended predominantly for complications of IE,
such as recurrent embolic events, congestive heart failure
unresponsive to medical management, or the presence of
perivalvular extention.1 In our study, 66 patients underwent
surgical intervention. Table 4 demonstrates the clinically
significant outcome variables that lead to mortality.
Limitations of this study include restricted sample size
(NZ 87) and limited versatility, meaning only one surgical
group in one location (Cincinnati, OH) was responsible for
the data provided in our series. Because the study was con-
ducted at a single location, regional variation in the diagno-
sis and treatment of IE may have influenced results. Some
of the strengths of the study were that the data was col-
lected prospectively and the data were reliable. The
Cardiac, Vascular, and Thoracic Surgery, Inc. database
included a wide variety of variables that were controlled
and randomly audited by a single physician.In conclusion, factors that serve as statistically significant
clinical predictors of mortality from IE are: age, longer pump
times, and unstable hemodynamic status. Patients with
independent outcome variables such as longer operative
procedures, positive venous or arterial line cultures, or
complications (renal, neurological, intra-operative, pulmo-
nary) were found to have an increased risk for in-house death.
Infective endocarditis is still recognized as a complex disease
and these findings offer a means of early risk stratification
of patients with IE and thus may identify higher-risk patients
for more aggressive treatment or interventions.
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